BioLineRx reports publication in peer review journal of positive phase 1/2 results in stem cell mobilization for multiple myeloma

November 20, 2013

BioLineRx, a biopharmaceutical development company, announced today the publication of results showing that BL-8040 (formerly known as BKT-140) enables the efficient mobilization of stem cells from the bone marrow into the peripheral blood, thus facilitating autologous stem cell transplantation in multiple myeloma patients. The research was published in the journal, Clinical Cancer Research. (The Wall Street Journal)